{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:26:29Z","timestamp":1771863989890,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.intimp.2025.114395","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T20:55:53Z","timestamp":1741985753000},"page":"114395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Elucidating the inhibitory role of miR-140-5p in SARS-CoV-2 infection"],"prefix":"10.1016","volume":"152","author":[{"given":"Xiaoyan","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiuxiang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jintao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.intimp.2025.114395_bb0005","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.cell.2015.02.025","article-title":"Hepatitis C virus RNA functionally sequesters miR-122","volume":"160","author":"Luna","year":"2015","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.intimp.2025.114395_bb0010","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00728-18","article-title":"The coronavirus transmissible gastroenteritis virus evades the type I interferon response through IRE1\u03b1-mediated manipulation of the MicroRNA miR-30a-5p\/SOCS1\/3 Axis","volume":"92","author":"Ma","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2025.114395_bb0015","series-title":"Human Coronavirus OC43 Nucleocapsid Protein Binds MicroRNA 9 and Potentiates NF-\u03baB Activation","first-page":"54","volume":"88 (1)","author":"Lai","year":"2014"},{"issue":"3","key":"10.1016\/j.intimp.2025.114395_bb0020","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.chom.2017.01.015","article-title":"SARS-CoV-encoded small RNAs contribute to infection-associated lung pathology","volume":"21","author":"Morales","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.intimp.2025.114395_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/967946","article-title":"A computational approach for predicting role of human MicroRNAs in MERS-CoV genome","volume":"2014","author":"Hasan","year":"2014","journal-title":"Adv. Bioinforma."},{"issue":"4","key":"10.1016\/j.intimp.2025.114395_bb0030","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00028-20","article-title":"Coronavirus disease 2019-COVID-19","volume":"33","author":"Dhama","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.intimp.2025.114395_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.104832","article-title":"The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review","volume":"91","author":"Marchi","year":"2021","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.intimp.2025.114395_bb0040","article-title":"Role of microRNAs in COVID-19 with implications for therapeutics","volume":"144","author":"Arghiani","year":"2021","journal-title":"Biomed. Pharmacoth. Biomed. Pharmacoth."},{"issue":"5","key":"10.1016\/j.intimp.2025.114395_bb0045","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s40265-021-01474-5","article-title":"MicroRNA mimics or inhibitors as antiviral therapeutic approaches against COVID-19","volume":"81","author":"Hum","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2025.114395_bb0050","series-title":"MicroRNAs and SARS-CoV-2 Life Cycle, Pathogenesis, and Mutations: Biomarkers or Therapeutic Agents? Cell Cycle (Georgetown, Tex.)","first-page":"143","volume":"20 (2)","author":"Abedi","year":"2021"},{"issue":"8","key":"10.1016\/j.intimp.2025.114395_bb0055","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00284-023-03365-2","article-title":"PBMC MicroRNAs: promising biomarkers for the differential diagnosis of COVID-19 patients with abnormal coagulation indices","volume":"80","author":"Kasho","year":"2023","journal-title":"Curr. Microbiol."},{"issue":"23","key":"10.1016\/j.intimp.2025.114395_bb0060","doi-asserted-by":"crossref","first-page":"19735","DOI":"10.18632\/oncotarget.3771","article-title":"Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy","volume":"6","author":"Zhai","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.intimp.2025.114395_bb0065","doi-asserted-by":"crossref","first-page":"122","DOI":"10.7150\/ijbs.14770","article-title":"miR-15a-3p and miR-16-1-3p negatively regulate Twist1 to repress gastric cancer cell invasion and metastasis","volume":"13","author":"Wang","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2025.114395_bb0070","series-title":"Hypothesis: do miRNAs targeting the leucine-rich Repeat Kinase 2 Gene (LRRK2) influence Parkinson\u2019s disease susceptibility?","first-page":"224","volume":"20 (4)","author":"Y\u0131lmaz","year":"2016"},{"key":"10.1016\/j.intimp.2025.114395_bb0075","doi-asserted-by":"crossref","first-page":"1007737","DOI":"10.3389\/fimmu.2022.1007737","article-title":"Lactobacillus johnsonii YH1136 plays a protective role against endogenous pathogenic bacteria induced intestinal dysfunction by reconstructing gut microbiota in mice exposed at high altitude","volume":"13","author":"Wan","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114395_bb0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12863-021-00997-w","article-title":"Hsa-mir-548 family expression in human reproductive tissues","volume":"22","author":"Rooda","year":"2021","journal-title":"BMC Genomic. Data"},{"issue":"16","key":"10.1016\/j.intimp.2025.114395_bb0085","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.7150\/thno.32543","article-title":"The miR-561-5p\/CX(3)CL1 signaling Axis regulates pulmonary metastasis in hepatocellular carcinoma involving CX(3)CR1(+) natural killer cells infiltration","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.intimp.2025.114395_bb0090","first-page":"207","article-title":"The importance of miRNA identification during respiratory viral infections","volume":"3","author":"Martinez-Espinoza","year":"2021","journal-title":"J. Cell. Immun."},{"key":"10.1016\/j.intimp.2025.114395_bb0095","series-title":"Comprehensive Analysis of Potential ceRNA Network and Different Degrees of Immune Cell Infiltration in Acute Respiratory Distress Syndrome","volume":"13","author":"Hu","year":"2022"},{"key":"10.1016\/j.intimp.2025.114395_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110548","article-title":"SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: an in-silico approach","volume":"130","author":"Yousefi","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.intimp.2025.114395_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22116094","article-title":"In silico and in vitro analyses validate human MicroRNAs targeting the SARS-CoV-2 3\u2019-UTR","volume":"22","author":"Barreda-Manso","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2025.114395_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22116094","article-title":"In silico and in vitro analyses validate human micrornas targeting the SARS-CoV-2 3'-UTR","volume":"22","author":"Barreda-Manso","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2025.114395_bb0115","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/jclinpath-2014-202352","article-title":"MicroRNA as potential biomarker in HCV-associated diffuse large B-cell lymphoma","volume":"67","author":"Augello","year":"2014","journal-title":"J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114395_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109839","article-title":"Role of miR-2392 in driving SARS-CoV-2 infection","volume":"37","author":"McDonald","year":"2021","journal-title":"Cell Rep."},{"issue":"W1","key":"10.1016\/j.intimp.2025.114395_bb0130","doi-asserted-by":"crossref","first-page":"W181","DOI":"10.1093\/nar\/gkw459","article-title":"miRNAFold: a web server for fast miRNA precursor prediction in genomes","volume":"44","author":"Tav","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2025.114395_bb0135","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkm368","article-title":"MiPred: classification of real and pseudo microRNA precursors using random forest prediction model with combined features","volume":"35","author":"Jiang","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.intimp.2025.114395_bb0140","doi-asserted-by":"crossref","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: from microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.intimp.2025.114395_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102711","article-title":"CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death","volume":"24","author":"L\u00e9vy","year":"2021","journal-title":"iScience"},{"issue":"23","key":"10.1016\/j.intimp.2025.114395_bb0150","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1016\/j.cell.2021.10.023","article-title":"COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas","volume":"184","author":"Ren","year":"2021","journal-title":"Cell"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925003856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925003856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:14:14Z","timestamp":1757913254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925003856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":29,"alternative-id":["S1567576925003856"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114395","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elucidating the inhibitory role of miR-140-5p in SARS-CoV-2 infection","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114395"}}